Evaluation of oxidative stress markers and cardiovascular risk factors in Fabry Disease patients
AUTOR(ES)
Müller, Karen B., Galdieri, Luciano C., Pereira, Vanessa G., Martins, Ana M., D'Almeida, Vânia
FONTE
Genetics and Molecular Biology
DATA DE PUBLICAÇÃO
17/05/2012
RESUMO
Fabry Disease, an X-linked inborn error of metabolism, is characterized by progressive renal insufficiency, with cardio and cerebrovascular involvement. Homocysteine (Hcy) is considered a risk factor for vascular diseases, but the mechanisms by which it produces cardiovascular damage are still poorly understood. Regarding the vascular involvement in FD patients, the analysis of factors related to thromboembolic events could be useful to improving our understanding of the disease. The aim of this study was to evaluate plasma Hcy and other parameters involved in the methionine cycle, as well as oxidative stress markers. The sample consisted of a group of 10 male FD patients and a control group of 8 healthy individuals, paired by age. Venous blood was collected for Hcy determination, molecular analysis, identification of thiobarbituric acid reactive substances, total glutathione and antioxidant enzymes activity, as well as vitamins quantification. Comparative analysis of FD patients versus the control group indicated hyperhomocysteinemia in 8 of the 10 FD patients, as well as a significant increase in overall glutathione levels and catalase activity. It is inferred that FD patients, apart from activation of the antioxidant system, present increased levels of plasma Hcy, although this is probably unrelated to common alterations in the methionine cycle.
Documentos Relacionados
- Evaluation of cardiovascular disease risk factors in patients with mycosis fungoides
- Comparison of risk factors for cardiovascular disease in hemodialysis and peritoneal dialysis patients
- Profile of cardiovascular risk factors and mortality in patients with symptomatic peripheral arterial disease
- Multiple Risk Factors in Cardiovascular Disease
- Multiple Risk Factors in Cardiovascular Disease